A Phase I, Multicenter, Dose Escalation Study of CAT-8015 in Participants With Chronic Leukemia

NCT00587457 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

11

Enrollment

INDUSTRY

Sponsor class

Stopped The study is terminated early due to unavailability of investigational product.

Conditions

Leukemia, Lymphoma, Chronic Lymphocytic
Leukemia, Prolymphocytic Leukemia, Small
Lymphocytic Lymphoma, Moxetumomab Pasudotox

Interventions

DRUG: CAT-8015 5 mcg/kg
DRUG: CAT-8015 10 mcg/kg
DRUG: CAT-8015 20 mcg/kg

Sponsor

MedImmune LLC

Collaborators

[object Object]